Results 201 to 210 of about 142,502 (333)

Psychophysiological responses of women with polycystic ovary syndrome during sessions of high-intensity interval training

Human Movement, 2022
Isis Kelly Dos Santos, Luiz Fernando Farias-Junior, Gabriel Soares Pichini, Carlindo Daniel De Medeiros Lopes Ferreira, Victor Sabino Queiros, Gustavo Mafaldo Soares, Breno Guilherme De Araújo Tinoco Cabral, Tecia Maria De Oliveira Maranhão, Paulo Moreira Silva Dantas   +8 more
doaj   +1 more source

An Open‐Source Pipeline for Calcium Imaging and All‐Optical Physiology in Human Stem Cell‐Derived Neurons

Advanced Science, Volume 13, Issue 26, 8 May 2026.
This work introduces an open‐source all‐optical platform for functional phenotyping of human stem cell‐derived neurons. The system integrates optogenetics, calcium imaging, automated acquisition, and analysis to resolve single‐cell and network activity, enabling longitudinal measurements, disease modeling, and pharmacological screening in preclinical ...
Wardiya Afshar‐Saber, Federico M. Gasparoli, Ziqin Yang, Nicole A. Teaney, Rachel Hobson, Lahin Lalani, Gayathri Srinivasan, Dosh Whye, Ranit Karmakar, Elizabeth D. Buttermore, Kellen D. Winden, Cidi Chen, Mustafa Sahin   +12 more
wiley   +1 more source

Visceral adiposity and insulin resistance in polycystic ovarian syndrome - A cross-sectional, observational study. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Sridharan A, Guddeti A, Vasamsetti SR, Kumar S, Aleem S, Mashetty S, Alekya LA, Hari Kumar K.   +7 more
europepmc   +1 more source

Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation

Advanced Science, Volume 13, Issue 26, 8 May 2026.
ABSTRACT Extracellular vesicles (EVs) are nanoscale mediators of intercellular communication with diverse molecular cargoes that reflect their cell of origin. Advances in isolation, detection, and single‐particle analytics have revealed increasing molecular and functional heterogeneity, while exposing limitations in how EV identity and activity are ...
David J. Lundy, Zoe L. Chau, Sheng‐You Chen, Nanami Fujisawa, John J. Hill, Barnett M. Hsu, Joanne K. Liu, Karol W. Mai, James J. Lai   +8 more
wiley   +1 more source

Opportunities to improve the care of individuals with polycystic ovary syndrome in Canada: Systematic review. [PDF]

Can Fam Physician
Patrick H, McAlister L, Pourtousi A, Badesha J, Liu SL, Tunio S, Clemens KK.   +6 more
europepmc   +1 more source

Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS. [PDF]

FASEB J
In a rat model of DHEA/DHT‐induced PCOS and in granulosa cells (GCs), upregulated DNMT1, DNMT3A, and DNMT3B inhibit TXNIP degradation, leading to TXNIP accumulation, which drives ovarian fibrosis and tissue injury. ABSTRACT Hyperandrogenism and elevated thioredoxin‐interacting protein (TXNIP) are potential causes of infertility in women with polycystic
Weng Y, Shangguan L, Shen Q, Zhu Z, Zhang Y, Zhang J, Yan G, Shen S, Xiang Z, Ruan J, Wen Y, Wang D, Wang Y.   +12 more
europepmc   +2 more sources

Efficacy of Fertility‐Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Cancer Medicine, Volume 15, Issue 5, May 2026.
Molecular profiles and outcomes of CR rate in 74 cases. ABSTRACT Objective To investigate the impact of various molecular characteristics on the outcomes of fertility‐preserving therapy in patients with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH).
Xue‐Qian Qian, Hao‐Hui Fu, Xiao‐Yun Wan, Dong‐Xiao Hu, Yuan‐Ming Shen   +4 more
wiley   +1 more source

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome. [PDF]

Front Endocrinol (Lausanne)
Han Q, Zhao J, Li M, Xin M, Yin X, He J.
europepmc   +1 more source

Maternal‐to‐Infant Transfer of Medications for Type 2 Diabetes Mellitus Via Breastmilk: A Systematic Review of Available Evidence and Clinical Guidelines

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1223-1234, May 2026.
This review evaluates the available pharmacokinetic data on the plasma‐to‐breastmilk transfer of first‐ and second‐line T2DM drugs against available clinical guideline recommendations. A list of drug therapies for treating T2DM was generated from national and international clinical guidelines.
Katherine Richardson, Joshua Kiptoo, Beatrice Mpora Odongkara, Francis Williams Ojara, Catriona Waitt   +4 more
wiley   +1 more source

Are serum MOTS-c levels and MOTS-c m.1382A>C polymorphism related to polycystic ovary syndrome? [PDF]

Arch Endocrinol Metab
Filibeli BE, Dedemoglu F, Garipçin P, Bulut S, Başok Bİ, Kizildağ S, Dündar B, Çatli G.   +7 more
europepmc   +1 more source